Torsade de pointes caused by hydroxychloroquine use in a patient with a severe form of COVID-19

1Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

We report the case of a previously healthy patient who was severely affected by COVID-19 and developed torsade de pointes after hydroxychloroquine-Azithromycin administration. Critically ill COVID-19 patients have multiple abnormalities that lead to an unsteady state in heart electricity, and can potentiate hydroxychloroquine cardiotoxicity. In light of this clinical observation, and until the efficacy of this association is proven, we plead against its use in critically ill COVID-19 patients.

Cite

CITATION STYLE

APA

Zarrouki, Y., Rebahi, H., Rhezali, M., Douirek, F., Ziad, A., & Samkaoui, M. A. (2020). Torsade de pointes caused by hydroxychloroquine use in a patient with a severe form of COVID-19. Southern African Journal of Critical Care, 36(1), 12–13. https://doi.org/10.7196/SAJCC.2020.V36I1.449

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free